Published Year: 2023
Next-Generation IVD (In vitro diagnostics) Market - A Global and Regional Analysis: Focus on Product
The next-generation IVD market was valued at $86.21 billion in 2022 and is expected to reach...
Market Research Report
A quick peek into the report
Table of Contents
1.1 Product Definition
1.1.1 Inclusion and Exclusion Criteria
1.2 Market Scope
1.2.1 Key Questions Answered in the Report
1.3 Research Methodology
1.3.1 Next-Generation IVD Market: Research Methodology
1.3.2 Data Sources
1.3.2.1 Primary Data Sources
1.3.2.2 Secondary Data Sources
1.3.3 Market Estimation Model
1.3.4 Criteria for Company Profiling
2.1 Introduction
2.1.1 Next-Generation IVD Market Outlook
2.1.1.1 POC-IVD
2.1.1.2 Diagnostic Expenditures
2.1.1.3 Pricing Patterns of Next-Generation IVD
2.1.2 Market Size and Growth Potential
2.1.2.1 Short-Term Impact (2020-2025)
2.1.2.2 Long-Term Impact (2026-2033)
2.1.3 Product Benchmarking by Next- Generation In-vitro Diagnostics Market, (by Type)
2.2 COVID-19 Impact on the Next-Generation IVD Market
2.2.1 Impact on Operations
2.2.2 COVID-19 Impact: Current Scenario of the Market
2.2.3 Pre-COVID Assessment
2.2.4 Post-COVID-19 Market Assessment
3.1 Legal Requirements
3.1.1 Legal Requirements and Framework in Asia-Pacific
4.1 Overview
4.2 Asia-Pacific
4.2.1 Market Dynamics
4.2.2 Market Size and Forecast
4.2.2.1 Asia-Pacific Next-Generation IVD Market (by End User)
4.2.2.2 Asia-Pacific Next-Generation IVD Market (by Type)
4.2.2.2.1 Asia-Pacific Next-Generation Core Laboratory IVD Market, (by Type)
4.2.2.3 Asia-Pacific Next-Generation IVD Market (by Country)
4.2.2.3.1 China
4.2.2.3.1.1 Market Size and Forecast
4.2.2.3.1.1.1 China Next-Generation IVD Market (by End User)
4.2.2.3.1.1.2 China Next-Generation IVD Market (by Type)
4.2.2.3.2 Japan
4.2.2.3.2.1 Market Size and Forecast
4.2.2.3.2.1.1 Japan Next-Generation IVD Market (by End User)
4.2.2.3.2.1.2 Japan Next-Generation IVD Market (by Type)
4.2.2.3.3 India
4.2.2.3.3.1 Market Size and Forecast
4.2.2.3.3.1.1 India Next-Generation IVD Market (by End User)
4.2.2.3.3.1.2 India Next-Generation IVD Market (by Type)
4.2.2.3.4 Australia
4.2.2.3.4.1 Market Size and Forecast
4.2.2.3.4.1.1 Australia Next-Generation IVD Market (by End User)
4.2.2.3.4.1.2 Australia Next-Generation IVD Market (by Type)
4.2.2.3.5 South Korea
4.2.2.3.5.1 Market Size and Forecast
4.2.2.3.5.1.1 South Korea Next-Generation IVD Market (by End User)
4.2.2.3.5.1.2 South Korea Next-Generation IVD Market (by Type)
4.2.2.3.6 Rest-of-Asia-Pacific
4.2.2.3.6.1 Market Size and Forecast
4.2.2.3.6.1.1 Rest-of-Asia-Pacific Next-Generation IVD Market (by End User)
4.2.2.3.6.1.2 Rest-of-Asia-Pacific Next-Generation IVD Market (by Type)
5.1 Overview
5.2 Next-Generation IVD Market Ecosystem Active Players
5.3 Sysmex Corporation
5.3.1 Company Overview
5.3.2 Role of Sysmex Corporation in the Next-Generation IVD Market
5.3.3 Financials
5.3.4 Recent Developments
5.3.4.1 Business Strategies
5.3.5 Analyst Perspective
Table 1: Impact Analysis of Market Drivers, and Restraints on the Asia-Pacific Next-Generation IVD Market
Table 2: Impact of COVID-19 on Different Countries
Table 3: Asia-Pacific: Market Dynamics
Table 4: Next-Generation IVD Market, Active Players
Figure 1: Facts about Next-Generation IVD Market
Figure 2: Equipment’s used for Next-Generation In-Vitro Diagnostics
Figure 3: Asia-Pacific Next-Generation IVD Market, $Billion, 2022 and 2033
Figure 4: Trend Analysis of Next-Generation In-vitro Diagnostics Ecosystem
Figure 5: Common Chronic Conditions for Population Above 65 years
Figure 6: Key Challenges in the Asia-Pacific Next-Generation IVD Market based on Primary Respondents
Figure 7: New In-Vitro Diagnostics Regulations (IVDR) and Medical Device Regulation (MDR)
Figure 8: Major Highlights Witnessed in the Next-Generation IVD Market During COVID-19 Impact
Figure 9: Role of POC Diagnostics in Next-Generation IVD Market During Pandemic
Figure 10: Leading and Emerging Companies in the Next-Generation IVD Ecosystem
Figure 11: Leading Companies in the Next-Generation IVD Ecosystem and Their Market Share (%)
Figure 12: Key Developments Undertaken by Companies in the Next-Generation IVD Market, July 2019-June 2023
Figure 13: Product Benchmarking of Next-Generation In-Vitro Diagnostics Ecosystem (by Test)
Figure 14: Asia-Pacific Next-Generation IVD Market (by Type), Share (%), 2022 and 2033
Figure 15: Asia-Pacific Next-Generation IVD Market (by End User), Share (%), 2022 and 2033
Figure 16: Next-Generation IVD Market: Research Methodology
Figure 17: Primary Research Methodology
Figure 18: Bottom-Up Approach (Segment-Wise Analysis)
Figure 19: Top-Down Approach (Segment-Wise Analysis)
Figure 20: Asia-Pacific Next-Generation IVD Market, $Billion, 2022-2033
Figure 21: Product Benchmarking of Next-Generation In-vitro Diagnostics Market (by Type)
Figure 22: In-Vitro Diagnostic Trends during the COVID-19 Pandemic
Figure 23: Timeline of IVDR 2017/746
Figure 24: Next-Generation IVD Market (by Region), Share (%), 2022
Figure 25: Next-Generation IVD Market (by Region), $Billion, 2022-2033
Figure 26: Asia-Pacific Next-Generation IVD Market, $Billion, 2022-2033
Figure 27: Asia-Pacific Next-Generation IVD Market (by End User), $Billion, 2022-2033
Figure 28: Asia-Pacific Next-Generation IVD Market (by Type), $Billion, 2022-2033
Figure 29: Asia-Pacific Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
Figure 30: Asia-Pacific Next-Generation IVD Market (by Country), $Billion, 2022-2033
Figure 31: China Next-Generation IVD Market, $Billion, 2022-2033
Figure 32: China Next-Generation IVD Market (by End User), $Billion, 2022-2033
Figure 33: China Next-Generation IVD Market (by Type), $Billion, 2022-2033
Figure 34: China Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
Figure 35: Japan Next-Generation IVD Market, $Billion, 2022-2033
Figure 36: Japan Next-Generation IVD Market (by End User), $Billion, 2022-2033
Figure 37: Japan Next-Generation IVD Market (by Type), $Billion, 2022-2033
Figure 38: Japan Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
Figure 39: India Next-Generation IVD Market, $Billion, 2022-2033
Figure 40: India Next-Generation IVD Market (by End User), $Billion, 2022-2033
Figure 41: India Next-Generation IVD Market (by Type), $Billion, 2022-2033
Figure 42: India Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
Figure 43: Australia Next-Generation IVD Market, $Billion, 2022-2033
Figure 44: Australia Next-Generation IVD Market (by End User), $Billion, 2022-2033
Figure 45: Australia Next-Generation IVD Market (by Type), $Billion, 2022-2033
Figure 46 Australia Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
Figure 47: South Korea Next-Generation IVD Market, $Billion, 2022-2033
Figure 48: South Korea Next-Generation IVD Market (by End User), $Billion, 2022-2033
Figure 49: South Korea Next-Generation IVD Market (by Type), $Billion, 2022-2033
Figure 50: South Korea Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
Figure 51: Rest-of-Asia-Pacific Next-Generation IVD Market, $Billion, 2022-2033
Figure 52: Rest-of-Asia-Pacific Next-Generation IVD Market (by End User), $Billion, 2022-2033
Figure 53: Rest-of-Asia-Pacific Next-Generation IVD Market (by Type), $Billion, 2022-2033
Figure 54: Rest-of-Asia-Pacific Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
Figure 55: Total Number of Companies Profiled
Figure 56: Sysmex Corporation: Product Portfolio
Figure 57: Sysmex Corporation: Overall Financials, $Million, 2020-2022
Figure 58: Sysmex Corporation: Revenue (by Segment), $Million, 2020-2022
Figure 59: Sysmex Corporation: Revenue (by Region), $Million, 2020-2022
Figure 60: Sysmex Corporation: R&D Expenditure, $Million, 2020-2022
Asia-Pacific Next-Generation IVD Market Report Coverage
|
Asia-Pacific Next-Generation IVD Market |
|||
|
Base Year |
2022 |
Market Size in 2023 |
$21.43 Billion |
|
Forecast Period |
2023-2033 |
Value Projection and Estimation by 2033 |
$42.35 Billion |
|
CAGR During Forecast Period |
7.05% |
|
|
How Can This Report Add Value to an Organization?
Product/Innovation Strategy: The next-generation IVD market has been extensively segmented on the basis of various categories, such as type, end user, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.
Competitive Strategy: The next-generation IVD market has numerous startups paving their way into manufacturing kits, panels, assays, and instruments and entering the market. Key players in the next-generation IVD market analyzed and profiled in the study involve established players that offer various kinds of disease-specific panels and multiplex instruments.
Introduction to Asia-Pacific Next-Generation IVD (In vitro diagnostics) Market
The Asia-Pacific next-generation IVD market was valued at $21.43 billion in 2023 and is expected to reach $42.35 billion by 2033, growing at a CAGR of 7.05% between 2023 and 2033. The emergence of innovative technologies in diagnostics holds promise for revitalizing the growth of the next-generation In Vitro Diagnostics (IVD) market. Molecular diagnostics, genomics, and Next-Generation Sequencing (NGS) are anticipated to play pivotal roles in driving this growth, offering fresh opportunities for enhanced disease detection and ultimately transforming patient outcomes.
Market Introduction
The Asia-Pacific (APAC) region is witnessing significant advancements and growth in the Next-Generation In Vitro Diagnostics (IVD) market. This expansion is fueled by several key factors. Firstly, the increasing prevalence of chronic diseases and infectious ailments necessitates more accurate and efficient diagnostic solutions. Secondly, rapid urbanization and rising healthcare expenditures in countries like China, India, and Japan are driving the adoption of advanced diagnostic technologies. Thirdly, growing awareness among healthcare providers and patients regarding the benefits of personalized medicine and early disease detection is spurring demand for innovative IVD solutions. Additionally, supportive government initiatives aimed at improving healthcare infrastructure and promoting research and development activities further contribute to market growth in the APAC region.
Market Segmentation:
Segmentation 1: by Type
• Core Laboratory Diagnostics
• POC Testing
• Molecular Diagnostics
Segmentation 2: by End User
• Hospitals and Clinics
• Diagnostic Laboratories
• Academic and Research Institutions
• Other End Users
Segmentation 3: by Country
• Japan
• India
• China
• South Korea
• Australia
• Rest-of-Asia-Pacific
Asia-Pacific Next-Generation IVD Market
Analysis and Forecast, 2023-2033
Some Faq's
Frequently Asked Questions
This report will be useful for firms planning to enter the next-generation IVD market and investors who want to invest in the product. Additionally, established market players in this market can also benefit from this report. This is because the report discusses the benefits of using next-generation IVD and the latest advancements in the market right now.
The next-generation IVD market was valued at $86.21 billion in 2022 and is expected to reach $152.62 billion by 2033, growing at a CAGR of 5.41% between 2023 and 2033.
Next-generation IVD technologies offer several advantages, including faster turnaround times for test results, improved accuracy in diagnosing complex diseases, enhanced capabilities for personalized medicine and targeted therapies, and the ability to detect diseases at earlier stages when treatment is most effective.
Next-generation IVD technologies enable the analysis of genetic variations, biomarkers, and other molecular signatures that can inform personalized treatment strategies. By providing insights into an individual's unique genetic makeup and disease characteristics, these technologies support the delivery of targeted therapies and optimized patient care.
Next-generation IVD technologies offer rapid and accurate methods for identifying pathogens, tracking disease transmission patterns, and monitoring outbreaks in real-time. This capability is essential for early detection, containment, and management of infectious diseases, including epidemics and pandemics.
Similar Product
You may also like